Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.200 | 12 | 68158715 | intron variant | TGTGTGTGTGTG/-;TG;TGTG;TGTGTG;TGTGTGTG;TGTGTGTGTG;TGTGTGTGTGTGTG;TGTGTGTGTGTGTGTG;TGTGTGTGTGTGTGTGTG;TGTGTGTGTGTGTGTGTGTG;TGTGTGTGTGTGTGTGTGTGTG;TGTGTGTGTGTGTGTGTGTGTGTG;TGTGTGTGTGTGTGTGTGTGTGTGTG | delins |
|
0.700 | 0 | ||||||||||||
|
0.925 | 0.200 | 12 | 68158715 | intron variant | TGTGTGTGTGTG/-;TG;TGTG;TGTGTG;TGTGTGTG;TGTGTGTGTG;TGTGTGTGTGTGTG;TGTGTGTGTGTGTGTG;TGTGTGTGTGTGTGTGTG;TGTGTGTGTGTGTGTGTGTG;TGTGTGTGTGTGTGTGTGTGTG;TGTGTGTGTGTGTGTGTGTGTGTG;TGTGTGTGTGTGTGTGTGTGTGTGTG | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Nervous System Diseases | 0.700 | 0 | |||||||||||
|
0.851 | 0.280 | 12 | 68157416 | intron variant | G/A | snv | 0.76 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.851 | 0.280 | 12 | 68157416 | intron variant | G/A | snv | 0.76 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.280 | 12 | 68157416 | intron variant | G/A | snv | 0.76 |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.280 | 12 | 68157416 | intron variant | G/A | snv | 0.76 |
|
Skin and Connective Tissue Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Immune System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Infections | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.716 | 0.400 | 12 | 68157629 | intron variant | C/T | snv | 0.75 |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Infections; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.695 | 0.440 | 12 | 68161231 | intron variant | G/A;C | snv |
|
Infections | 0.010 | 1.000 | 1 | 2014 | 2014 |